LAMIVUDINE
- UNII: 2T8Q726O95
- Formula: C8H11N3O3S
- Preferred Substance Name: LAMIVUDINE
- InChIKey: JTEGQNOMFQHVDC-NKWVEPMBSA-N
- 134678-17-4
- (-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE
- 2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, (2R-CIS)-
- 3TC
- 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]
- BCH 189, (-)-
- COMBIVIR COMPONENT LAMIVUDINE
- DELSTRIGO COMPONENT LAMIVUDINE
- EMTRICITABINE IMPURITY C [WHO-IP]
- EPIVIR
- EPZICOM COMPONENT LAMIVUDINE
- GR109714X
- GR-109714X
- KIVEXA COMPONENT LAMIVUDINE
- LAMIVUDINE [EMA EPAR]
- LAMIVUDINE [EP IMPURITY]
- LAMIVUDINE [EP MONOGRAPH]
- LAMIVUDINE [HSDB]
- LAMIVUDINE [INN]
- LAMIVUDINE [JAN]
- LAMIVUDINE [MART.]
- LAMIVUDINE [MI]
- LAMIVUDINE [ORANGE BOOK]
- LAMIVUDINE [USAN]
- LAMIVUDINE [USP MONOGRAPH]
- LAMIVUDINE [USP-RS]
- LAMIVUDINE [VANDF]
- LAMIVUDINE [WHO-DD]
- LAMIVUDINE [WHO-IP]
- LAMIVUDINE TEVA
- LAMIVUDINE TEVA PHARMA B.V.
- LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE
- LAMIVUDINUM [WHO-IP LATIN]
- NSC-760061
- TEMIXYS COMPONENT LAMIVUDINE
- TRIUMEQ COMPONENT LAMIVUDINE
- TRIZIVIR COMPONENT LAMIVUDINE
- VIROLAM
- ZEFFIX
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
